He played a key role in the development strategy for dapagliflozin, a leading SGLT-2 inhibitor that has become a global blockbuster in the treatment of metabolic diseases...
The strengthening of routine vaccine sales has contributed to a more balanced revenue mix and enhanced earnings visibility...
The Company has acquired the rights to develop, manufacture, and commercialise CARDAMYST (etripamil) nasal spray in Greater China...
VELSIPITY(R) was approved for marketing by China’s National Medical Products Administration (NMPA) in February this year...
The agreement outlines a joint commitment to applying AI across various chronic care scenarios and upgrading full-lifecycle health management solutions...
In this evolving landscape, PHASE Scientific’s exclusive partnership with Liger Medical signals a strategic shift toward portable, community-deployable cervical care solutions...
The approval was based on results from the Asian multicenter Phase 3 ENLIGHT UC study (ES101002) and the global ELEVATE UC Phase 3 program (ELEVATE UC 52 and ELEVATE UC 12)...
BMC128 was developed by Biomica, Evogene’s subsidiary, and is currently completing a Phase 1 clinical study, showing promising early clinical results...
This partnership with Liger Medical reflects our commitment to bringing leading global innovation into China’s healthcare system...
The ZEISS ARTEVO 750 ophthalmic microscope is another breakthrough in ZEISS's ophthalmic surgical microscope family that made its Chinese debut at the 2025 China International Import Expo (CIIE)...
